Hostname: page-component-7b7567c8c-slfcl Total loading time: 0 Render date: 2026-11-19T16:12:21.314Z Has data issue: false hasContentIssue false

Clinical Studies of a New Barbiturate (Nealbarbitone)

Published online by Cambridge University Press:  08 February 2018

A. A. Robin
Affiliation:
From Runwell Hospital and Southend General Hospital, Essex
D. P. Cronin
Affiliation:
From Runwell Hospital and Southend General Hospital, Essex
L. Scotton
Affiliation:
From Runwell Hospital and Southend General Hospital, Essex
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Brandström (1957) in Sweden, has recently resolved certain problems in the synthesis of barbiturates with a neopentyl group as one of the ring substituents and the resulting compound 5-allyl-5-neopentyl-barbituric acid∗ has been subjected to experimental studies which show it to be less hypnotic and anaesthetic than amylobarbitone or pentobarbitone sodium and yet protective to rats subjected to a stress situation after the technique of Jacobsen and Sonné (1955). The drug is rapidly absorbed after oral administration, and has a duration of action between that of amylobarbitone and phenobarbitone.

Information

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 
Submit a response

eLetters

No eLetters have been published for this article.